Molecular Partners AG (MOLN)
NASDAQ: MOLN · Real-Time Price · USD
4.518
-0.135 (-2.89%)
Aug 28, 2026, 12:16 PM EDT - Market open
Molecular Partners AG Market Cap
Molecular Partners AG has a market cap or net worth of $178.74 million as of August 28, 2026. Its market cap has increased by 31.11% in one year.
Market Cap
178.74M
Enterprise Value
98.00M
1-Year Change
31.11%
Ranking
Category
Stock Price
$4.52
ChartMarket Cap Chart
Since the IPO on June 16, 2021, Molecular Partners AG's market cap has decreased from $683.35M to $178.74M, a decrease of -73.84%. That is a compound annual growth rate of -22.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 178.74M | 11.62% |
| Dec 30, 2025 | 160.13M | -2.96% |
| Dec 30, 2024 | 165.01M | 22.94% |
| Dec 29, 2023 | 134.22M | -38.09% |
| Dec 30, 2022 | 216.81M | -65.56% |
| Dec 30, 2021 | 629.47M | -7.89% |
| Jun 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MediWound | 167.45M |
| Jyong Biotech | 165.54M |
| Milestone Pharmaceuticals | 163.46M |
| NRx Pharmaceuticals | 158.77M |
| Aardvark Therapeutics | 158.67M |
| Kazia Therapeutics | 157.58M |
| Tenaya Therapeutics | 157.27M |
| OnKure Therapeutics | 155.91M |